Biotech stocks are surging. How investors can play the new drug innovation boom

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

from US Top News and Analysis https://ift.tt/4he5KZO
https://ift.tt/c2naM3Q